Investments held at fair value (Tables)

12 Months Ended

Dec. 31, 2022

Interests in these investments were accounted for as shown below:


Investments held at fair value			$000's










Balance as of January 1, 2021			553,167
Sale of Karuna shares			(218,125)

Loss realised on sale of investments			(20,925)

Cash purchase of Vor preferred shares			500
Gain – change in fair value through profit and loss			179,271
Balance as of December 31, 2021 and January 1, 2022 before allocation of share in associate loss to long-term interest (*)			493,888
Investment in Sonde Preferred shares – Sonde deconsolidation			11,168
Sale of Karuna and Vor shares			(118,710)
Loss realised on sale of investments as a result of written call option			(29,303)
Cash Investment (Akili)			5,000

Gelesis Earn out shares received in SPAC exchange			14,214
Exchange of Gelesis preferred shares to Gelesis common shares			(92,303)
Loss – change in fair value through profit and loss			(32,060)

Balance as of December 31, 2022			251,892

(*) Share in associate losses allocated to long-term interest amounted to $96.7 million as of December 31, 2021 and January 1, 2022